MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound care and an emerging therapeutic biologics company, today released an investor presentation summarizing the reasons why the Company believes shareholders should support the Company’s three nominees for the Board of Directors (the “Board”) at the 2018 annual meeting of shareholders
June 5, 2019
· 8 min read